Lexology October 25, 2024
Ankura Consulting Group, LLC

Ankura’s Quarterly Healthcare Transactions Review

Ankura is pleased to present an overview of healthcare services transactions announced or closed during Q3 2024 in the United States. The total number of transactions decreased by 2.8 percent in the third quarter of 2024, following a decrease of 3.1 percent in the second quarter. Compared to the third quarter of 2023, transaction volumes for the third quarter of 2024 declined by 3.8 percent.

Notable Transactions Announced or Closed in Q3 1

  • On August 1, 2024, investment funds affiliated with TowerBrook Capital Partners and Clayton, Dubilier & Rice entered into a definitive agreement to acquire R1 RCM Inc. for approximately $8.9 billion. This transaction implies a price to Earnings Before Interest, Taxes, Depreciation,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Health System / Hospital, Mergers & Acquisitions / JV, Provider, Technology, Trends
Related Articles:
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Halozyme abandons its €2bn pursuit of Evotec
M&A Cyber Success Depends on Communication, an Honest Evaluation of Each Side’s Strengths & Risks, and an Open Mind
Halozyme Pulls €2B Acquisition Bid as Evotec Commits to Standalone Strategy
Weekly HCRE Briefing: AdventHealth to Acquire Two CHS Hospitals in FL | Kaiser Acquiring ASCs and MOBs

Share This Article